Wei Liu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Coronavirus Disease

Methicillin Resistant Staphylococcus Aureus

Chemotherapy Induced

Top Venues

Medical review (2021)

Infection and drug resistance

Pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Liu, Ping Yang, Ping Yang, Li Yang, Hongmei Jing, Li-Bo Zhao, Rongsheng Zhao
Clinical characteristics and pharmacokinetics of PAXLOVID in COVID-19 patients with hematological tumor. Medical review (2021) 4 (2) (2024)
Wei Liu, Ping Yang, Ping Yang, Li Yang, Hongmei Jing, Li-Bo Zhao, Rongsheng Zhao
Clinical characteristics and pharmacokinetics of PAXLOVID in COVID-19 patients with hematological tumor. Medical review (2021) 4 (2) (2024)
Na He, Fei Dong, Wei Liu, Suodi Zhai
A Systematic Review of Vancomycin Dosing in Patients with Hematologic Malignancies or Neutropenia. Infection and drug resistance 13 (2020)
Wei Liu, Tingting Yan, Ken Chen, Li Yang, Leslie Z Benet, Suo-di Zhai
Predicting Interactions between Rifampin and Antihypertensive Drugs Using the Biopharmaceutics Drug Disposition Classification System. Pharmacotherapy 40 (4) (2020)